Gastric Schwannomas Misdiagnosed as GIST: A Comparative Study of Clinic Strategies Based on Membrane Marker Detection

Authors

  • Quanyong Cheng Departments of Private Medical Center, General Surgery, Obstetrics and Gynecology and Medical Records Management, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China
  • Kun Zhao Departments of Private Medical Center, General Surgery, Obstetrics and Gynecology and Medical Records Management, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China
  • Jing Wang Departments of Private Medical Center, General Surgery, Obstetrics and Gynecology and Medical Records Management, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China
  • Yu Guo Departments of Private Medical Center, General Surgery, Obstetrics and Gynecology and Medical Records Management, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China
  • Hui Pang Departments of Private Medical Center, General Surgery, Obstetrics and Gynecology and Medical Records Management, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China

DOI:

https://doi.org/10.30683/1929-2279.2020.09.09

Keywords:

Gastric Schwannomas, GIST, diagnosis, Cell membrane marker, CD117, CD34, DOG-1, S-100.

Abstract

 Gastric schwannomas are one of the rarest gastric tumors originating from the nerve plexus of the gut wall. Because most of these tumors dont have any specific symptom and the majority of gastric mesenchymal tumors are gastrointestinal stromal tumors (GISTs), many are therefore misdiagnosed as GISTs. In addition, gastric schwannoma is the benign and slow-growing lesion in the stomach, but GISTs had poor outcomes due to lack of response to nonsurgical interventions. In our study, we analyzed two cases of these tumors. Computer tomography (CT), contrast-enhanced CT, gastroscopy, endoscopic ultrasonography (EUS) were applied to diagnose these two patients. In addition, histological examination and immunohistochemistry (IHC) were used to confirm the final diagnosis. All imageological examination such as CT, contrast-enhanced CT, gastroscopy and EUS, diagnosed these two patients as gastrointestinal stromal tumors. Surprisingly, after the subtotal gastric surgery, histological examination showed that these lesions were composed of spindle cells. Those cells presenting in the bundle or fence-like arrangement were mildly heterologous. The outcomes of immunohistochemistry of the cell membrane markers (CD117 / DOG-1 negative, CD34 mild positive or negative) were the exact opposite of the characteristic presentation of GIST. These pathological findings refused the primary diagnosis, and were in coincidence with the characteristics of gastric schwannomas. To our best knowledge, these tumors are really rare that only two cases could be reported and analyzed clinically. CT and EUS could help diagnose gastric schwannomas before pathological examination results, but in order to define this diagnosis correctly. Pathological examination and IHC staining should be applied after surgery. To avoid the recurrence, it is better to resect the lesion completely, regardless of the malignant or benign disease.

References

Zheng L, Wu X, Kreis ME, Yu Z, Feng L, Chen C, Xu B, Bu Z, Li Z, Ji J. Clinicopathological and immunohistochemical characterisation of gastric schwannomas in 29 cases. Gastroenterol Res Pract 2014; 2014: 202960. https://doi.org/10.1155/2014/202960

Herzberg M, Beer M, Anupindi S, Vollert K, Kroncke T. Imaging pediatric gastrointestinal stromal tumor (GIST). J Pediatr Surg 2018; 53: 1862-1870. https://doi.org/10.1016/j.jpedsurg.2018.03.022

Tatangelo F, Cantile M, Collina F, Belli A, DE Franciscis S, Bianco F, Botti G. Gastric schwannoma misdiagnosed as GIST: A case report with immunohistochemical and molecular study. Oncol Lett 2016; 11: 2497-2501. https://doi.org/10.3892/ol.2016.4281

Lavy DS, Paulin ET, Parker MI, Zhang B, Parker GS, Schwartz MR. H. Pylori in a gastric schwannoma: a case report. Ann Transl Med 2016; 4: 137. https://doi.org/10.21037/atm.2016.03.55

Bure I, Haller F, Zaletaev DV. Coding and Non-coding: Molecular Portrait of GIST and its Clinical Implication. Curr Mol Med 2018; 18: 252-259. https://doi.org/10.2174/1566524018666181004113436

Qian XH, Yan YC, Gao BQ, Wang WL. Prevalence, diagnosis, and treatment of primary hepatic gastrointestinal stromal tumors. World J Gastroenterol 2020; 26: 6195-6206. https://doi.org/10.3748/wjg.v26.i40.6195

Lasota J, Miettinen M. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours. Histopathology 2008; 53: 245-266. https://doi.org/10.1111/j.1365-2559.2008.02977.x

Ogasawara N, Sasaki M, Ishiguro H, Itoh Y, Nojiri S, Kubota E, Wada T, Kataoka H, Kuwabara Y, Joh T. Gastric schwannoma with adjacent external progression harbored aberrant NF2 gene. Dig Endosc 2009; 21: 192-195. https://doi.org/10.1111/j.1443-1661.2009.00885.x

Wang J, Ou J, Guo Y, Dai T, Li X, Liu J, Xia M, Liu L, He M. TBLR1 is a novel prognostic marker and promotes epithelial-mesenchymal transition in cervical cancer. Br J Cancer 2014; 111: 112-124. https://doi.org/10.1038/bjc.2014.278

Guo Y, Wang J, Li H, Liu W, Chen D, Zhao K, Liang X, Zhang Q, Yang Y, Chen G. Mediator subunit 23 overexpression as a novel target for suppressing proliferation and tumorigenesis in hepatocellular carcinoma. J Gastroenterol Hepatol 2015; 30: 1094-1103. https://doi.org/10.1111/jgh.12923

Guo Y, Wang J, Zhang L, Shen S, Guo R, Yang Y, Chen W, Wang Y, Chen G, Shuai X. Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma. Hepatology 2016; 63: 1240-1255. https://doi.org/10.1002/hep.28409

Hong SW, Cho WY, Kim JO, Chun CG, Shim KY, Bok GH, Um WH, Lee JE. Gastric schwannoma diagnosed by endoscopic ultrasonography-guided trucut biopsy. Clin Endosc 2013; 46: 284-287. https://doi.org/10.5946/ce.2013.46.3.284

Yoon W, Paulson K, Mazzara P, Nagori S, Barawi M, Berri R. Gastric schwannoma: a rare but important differential diagnosis of a gastric submucosal mass. Case Rep Surg 2012; 2012: 280982. https://doi.org/10.1155/2012/280982

Shelat VG, Li K, Naik S, Ng CY, Rao N, Rao J, Koura A. Abdominal schwannomas: case report with literature review. Int Surg 2013; 98: 214-218. https://doi.org/10.9738/INTSURG-D-13-00019.1

Williamson JM, Wadley MS, Shepherd NA, Dwerryhouse S. Gastric schwannoma: a benign tumour often mistaken clinically, radiologically and histopathologically for a gastrointestinal stromal tumour--a case series 2012. https://doi.org/10.1308/003588412X13171221590935

Ji JS, Lu CY, Mao WB, Wang ZF, Xu M. Gastric schwannoma: CT findings and clinicopathologic correlation. Abdom Imaging 2015; 40: 1164-1169. https://doi.org/10.1007/s00261-014-0260-4

Rha SE, Byun JY, Jung SE, Chun HJ, Lee HG, Lee JM. Neurogenic tumors in the abdomen: tumor types and imaging characteristics. Radiographics 2003; 23: 29-43. https://doi.org/10.1148/rg.231025050

Takeda M, Amano Y, Machida T, Kato S, Naito Z, Kumita S. CT, MRI, and PET findings of gastric schwannoma. Jpn J Radiol 2012; 30: 602-605. https://doi.org/10.1007/s11604-012-0093-4

Jung MK, Jeon SW, Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH, Bae HI. Gastric schwannomas: endosonographic characteristics. Abdom Imaging 2008; 33: 388-390. https://doi.org/10.1007/s00261-007-9291-4

Yang LH, Wang JO, Ma S, Zhu Z, Sun JX, Ding SL, Li G, Xu HT, Wang L, Dai SD, et al. Synchronous of gastric adenocarcinoma and schwannoma: report of a case and review of literatures. Int J Clin Exp Pathol 2015; 8: 1041-1045.

Loewen G, Zhuo Y, Zhuang Y, Jayawickramarajah J, Shan B. lincRNA HOTAIR as a novel promoter of cancer progression. J Can Res Updates 2014; 3: 134-140. https://doi.org/10.6000/1929-2279.2014.03.03.3

Fernandez JA, Frutos MD, Ruiz-Manzanera JJ. Incidental Gastrointestinal Stromal Tumors (GISTs) and Bariatric Surgery: A Review. Obes Surg 2020; 30: 4529-4541. https://doi.org/10.1007/s11695-020-04853-1

Khobragade KH, Patkar S, Goel M, Sahay A. Primary retroperitoneal GIST: Case report and review of literature. Indian J Cancer 2020; 57: 334-336. https://doi.org/10.4103/ijc.IJC_556_18

Downloads

Published

2020-01-27

How to Cite

Quanyong Cheng, Kun Zhao, Jing Wang, Yu Guo, & Hui Pang. (2020). Gastric Schwannomas Misdiagnosed as GIST: A Comparative Study of Clinic Strategies Based on Membrane Marker Detection. Journal of Cancer Research Updates, 9(1), 82–87. https://doi.org/10.30683/1929-2279.2020.09.09

Issue

Section

Articles

Similar Articles

You may also start an advanced similarity search for this article.